Nonrandom chromosomal imbalances in esophageal squamous cell carcinoma cell lines: Possible involvement of the ATF3 and CENPF Genes in the 1q32 amplicon

Japanese Journal of Cancer Research

Volumn 91, Issue 11, 2000, Pages 1126-1133

  Pimkhaokham, Atiphan ^a,b   Shimada, Yutaka ^c   Fukuda, Yohji ^a   Kurihara, Naoki ^a   Imoto, Issei ^a   Yang, Zeng Quan ^a   Imamura, Masayuki ^c   Nakamura, Yusuke ^d   Amagasa, Teruo ^b   Inazawa, Johji ^a  

^a Tokyo Medical and Dental University   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Amplicon map; Centromere protein F (CENPF); Comparative genomic hybridization (CGH); Esophageal squamous cell carcinoma (ESC); Human activating transcription factor 3 (ATF3)

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER; CARCINOMA CELL; CENTROMERE; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 18; CHROMOSOME 1Q; CHROMOSOME 20; CHROMOSOME 3; CHROMOSOME 4; CHROMOSOME 5P; CHROMOSOME 7P; CHROMOSOME 8; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME ARM; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE MAPPING; GENE OVEREXPRESSION; GENETIC ANALYSIS; GLIOBLASTOMA; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA; X CHROMOSOME;

ACTIVATING TRANSCRIPTION FACTOR 3; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; CARCINOMA, SQUAMOUS CELL; CHROMOSOMAL PROTEINS, NON-HISTONE; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; ESOPHAGEAL NEOPLASMS; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICROFILAMENT PROTEINS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0033635612     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2000.tb00895.x     Document Type: Article

References (41)

1. Estimates of the worldwide mortality from 25 cancers in 1990
2. Estimates of the worldwide incidence of 25 major cancers in 1990
3. Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: Reference to smoking, drinking and family history
4. Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies
5. Genetic instabilities in human cancers
6. The multistep nature of cancer
7. Comparative genomic hybridization and chromosomal instability in solid tumours
8. Amplification of the EGF receptor and c-myc genes in human esophageal cancers
9. Amplification and expression of the human cyclin D gene in esophageal cancer
10. The molecular biology of esophageal carcinoma
11. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: A review
12. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
13. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization
14. Detection of amplified DNA sequences by reverse chromosome painting using genomic tumor DNA as probe
15. Characterization of 21 newly established esophageal cancer cell lines
16. Identification of amplified DNA sequences on double minute chromosomes in a leukemic cell line KY821 by means of spectral karyotyping and comparative genomic hybridization
17. Comparative genomic hybridization of squamous cell carcinoma of the esophagus: The possible involvement of the DPI gene in the 13q34 amplicon
18. Gains, losses and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization
19. GAC1, a new member of the leucine-rich repeat superfamily on chromosome band 1q32.1, is amplified and overexpressed in malignant gliomas
20. Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations
21. Cloning, characterization and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP
22. Isolation of a candidate tumor suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene
23. DNA copy number losses in human neoplasms
24. Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms
25. MAD-related genes on 18q21.1, Smad2 and Smad4 are altered infrequently in esophageal squamous cell carcinoma
26. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas
27. Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma
28. Oral squamous cell carcinomas are characterized by a rather uniform pattern of genomic imbalances detected by comparative genomic hybridisation
29. Assessment of genomic imbalances in malignant fibrous histiocytomas by comparative genomic hybridization
30. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung
31. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization
32. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma
33. Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas
34. Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization
35. Loss gain of distinct regions of chromosome 1q in primary breast cancer
36. Molecular cytogenetics of primary breast cancer by CGH
37. Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization
38. DNA copy number amplifications in human neoplasms: Review of comparative genomic hybridization studies
39. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials
40. Nuclear autoantigen p330d/CENPF: A marker for cell proliferation in human malignancies